Amarin Corporation plc

Thursday, November 20, 2008

Thomas Lynch


Mr. Thomas Lynch joined Amarin in January 2000 as Chairman and Non-Executive Director and was appointed Chief Executive Officer in 2007. Between 1993 and 2004, Mr. Lynch was with Elan Corporation plc where he held a number of positions including Chief Financial Officer and Executive Vice Chairman. Mr. Lynch spear-headed Elan’s transition from a drug delivery technology provider to a fully integrated pharmaceutical company, through a number of acquisitions, including Athena Neurosciences, Inc. The Athena acquisition brought Elan its programs in multiple sclerosis, autoimmune diseases and Alzheimer’s disease. Mr. Lynch was also a founder of the specialty pharmaceutical company, Warner Chilcott plc. Mr. Lynch is and has been a board member of a number of biotechnology and healthcare companies. Mr. Lynch was a partner in the international accounting firm of KPMG, where he specialized in the provision of international corporate financial services.